Remdesivir Takes Top Spot for US Hospital Spending: Report

The COVID-19 drug remdesivir last year overtook AbbVie's 20-year-old arthritis drug Humira as the medicine that US hospitals spent the most on.
Reuters Health Information

source https://www.medscape.com/viewarticle/967713?src=rss